NIH

August 29, 2016

Nervous system’s role in hypertension

Increased activity of the “fight or flight” nervous system contributes to obesity-associated hypertension and may be a good therapeutic target for the disease.

By Leigh MacMillan
August 26, 2016

New breast cancer driver

Vanderbilt investigators have demonstrated that a certain protein complex drives tumor progression in aggressive breast cancers.

By Leigh MacMillan
August 25, 2016

VUMC lands NIH training grant in emergency care

Vanderbilt University Medical Center (VUMC) has received a five-year, $2 million award from the National Institutes of Health (NIH) to establish the Vanderbilt Emergency Care Research Training Program.

By VUMC News and Communications
chubby child playing with dog
August 25, 2016

Growth hormone for Prader-Willi

Children with Prader-Willi Syndrome who received growth hormone treatment had cognitive advantages compared to untreated patients.

By VUMC News and Communications
August 18, 2016

Program helps Ph.D. students find non-academic careers

In 2013, Vanderbilt University School of Medicine (VUSM) received one of 10 grants from the National Institutes of Health called BEST (Broadening Experiences in Scientific Training) to help train scientists for a variety of diverse careers.

By VUMC News and Communications
August 15, 2016

In search of new asthma therapies

A peptide molecule relaxes airway smooth muscle and may be a potential therapeutic for asthma that has become resistant to standard therapies.

By Leigh MacMillan
August 12, 2016

New culprit in nerve degeneration

Vanderbilt researchers have discovered that regulation of cell volume plays a role in nerve degeneration and peripheral neuropathies.
By Leigh MacMillan
August 11, 2016

NIH grant bolsters mass spectrometry research initiatives

The National Institutes of Health (NIH) has awarded a major renewal grant to continue the National Research Resource for Imaging Mass Spectrometry at Vanderbilt University School of Medicine.
By Bill Snyder
August 11, 2016

Research team takes aim at Ebola virus ‘decoy protein’

Using an antibody generated at Vanderbilt University Medical Center that neutralizes the Ebola virus, researchers at the Scripps Research Institute in La Jolla, California, have determined the structure of a “decoy” protein that may enable the virus to evade detection by the immune system.
By Bill Snyder
August 4, 2016

NIH grant boosts Englot’s epilepsy research efforts

Dario Englot, M.D., Ph.D., has received a grant from the National Institutes of Health to support his research into better understanding brain connectivity disturbances in patients with focal epilepsy.
By Tom Wilemon
July 28, 2016

Award bolsters study of alcohol’s impact on the brain

Vanderbilt University researcher Danny Winder, Ph.D., has received a MERIT Award from the National Institute of Alcohol Abuse and Addiction (NIAAA), part of the National Institutes of Health, for his contributions to understanding how alcohol affects the brain.
By Bill Snyder
July 28, 2016

NIH launches website for StoryCorps project

The National Institutes of Health (NIH) is launching its Voices of the NIH Community website, which features a collection of StoryCorps audio recordings from patients, families, researchers, doctors, nurses, staff and volunteers in both the NIH and Vanderbilt University Medical Center (VUMC) communities.
By Craig Boerner
July 20, 2016

Breast cancer: finding the smoking gun

A new method developed at Vanderbilt may help “inventory” all tumor-promoting genes.
By Bill Snyder
1 … 53 54 55 56 57 … 101